Promising immunotherapy drug now available for some lung cancer patients in England – Cancer Research UK
Cancer Research UK |
Promising immunotherapy drug now available for some lung cancer patients in England
Cancer Research UK Rose Gray, Cancer Research UK’s senior policy adviser, welcomed the decision to provide the promising drug, which is a kind of immunotherapy. “Immunotherapies such as Nivolumab are showing great promise for cancer patients, so it’s fantastic that this … Life-extending lung cancer drug will be made available on the NHSCambridge News Nivolumab to be made available to lung cancer patients in England and Wales, says NICEThe Pharmaceutical Journal |